COMMUNIQUÉS West-GlobeNewswire

Aura Biosciences to Participate in Upcoming Investor Conferences

28/08/2024 - 22:05

BOSTON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies to treat a range of solid tumors designed to preserve organ function [...]

PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024

28/08/2024 - 22:03

SAN JOSE, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, [...]

Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference

28/08/2024 - 22:01

LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the 2024 Wells Fargo Healthcare Conference on [...]

Xilio Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

28/08/2024 - 22:01

WALTHAM, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living [...]

60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements

28/08/2024 - 20:48

WASHINGTON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60P” or the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, [...]

Smart for Life to Attend the Newtopia Now 2024 Conference in Colorado

28/08/2024 - 19:28

Company Representatives to Explore Collaboration Opportunities at the Launch of the Industry’s Latest Premier Health & Wellness Event MIAMI, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“ [...]

Justin Baldoni’s doctor available to comment on “It Ends With Us” actor/director receiving groundbreaking regenerative therapy to treat chronic pain

28/08/2024 - 17:33

MISSISSAUGA, Ontario, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Justin Baldoni’s doctor, Dr. Adeel Khan, is available to comment on treating the “It Ends With Us” star for chronic knee and shoulder pain using cutting-edge [...]

AGAPE ATP Corporation Announces 1-for-20 Reverse Stock Split Effective August 30

28/08/2024 - 15:45

KUALA LUMPUR, MALAYSIA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- AGAPE ATP Corporation (NASDAQ: ATPC) (“Agape” or “the Company”,) today announced the filing of a Certificate of Change with the Secretary of State of Nevada, [...]

Immix Biopharma Expands U.S. Clinical Sites for relapsed/refractory AL Amyloidosis Trial NEXICART-2

28/08/2024 - 15:32

New Sites Expand Opportunities for Patient Access and Enrollment Clinical Trial Sites Added Include Cleveland Clinic, UC Davis, and Sutter Health Lead site Memorial Sloan Kettering Cancer Center (MSKCC) Data from ex-U.S [...]

IR-MED Appoints Ran Ziskind, Tech Entrepreneur, Growth Manager, and Inventor as Chief Executive Officer

28/08/2024 - 15:15

Rosh Pina, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) -- IR-MED Inc. , (“IR-MED” or the “Company”) (OTCQB:IRME), developer of a noninvasive artificial intelligence (AI) driven spectrographic analysis technology platform to [...]

Pasithea Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

28/08/2024 - 15:11

SOUTH SAN FRANCISCO, Calif. and MIAMI, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”) a clinical-stage biotechnology company developing PAS-004, a next- [...]

Appointment of Chase Hall, M.D., as Chief Medical Advisor

28/08/2024 - 15:01

Adds significant pulmonary expertise to help drive engagement with the medical community DURHAM, NC and LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), a commercial-stage medical device [...]

Galecto Announces Reverse Stock Split

28/08/2024 - 15:00

BOSTON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and fibrosis, today announced that it will [...]

Editas Medicine to Participate in Upcoming Investor Conferences

28/08/2024 - 15:00

CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that management will participate in the following upcoming investor [...]

Protect Pharmaceutical Corp. (PRTT) Finalizes the Merger with KARINCA Logistics

28/08/2024 - 15:00

ANKARA, Turkey, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. (OTC: PRTT) ($PRTT) (“Company”) announces it completed the necessary documentation to finalize the merger with KARINCA Logistics - www. [...]

Shuttle Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

28/08/2024 - 15:00

GAITHERSBURG, Md., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused [...]

AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions

28/08/2024 - 15:00

AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions PI-2620 is in Phase 3 development in Alzheimer’s disease by AC Immune’s partner, LMI This Fast [...]

Lord Jones® Live Resin Vapes and Ice Water Hash Pre-Rolls Now Available Across Canada

28/08/2024 - 15:00

TORONTO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) is expanding its portfolio for its Lord Jones ® brand with new innovations to bolster its lineup of [...]

HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

28/08/2024 - 14:57

NEW YORK and VIENNA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”, the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, [...]